Colean et al v. Pd-Rx Pharmaceuticals Inc et al

Filing 199

ORDER granting 4 Motion for Judgment; granting 25 Motion to Dismiss; granting 26 Motion to Dismiss; granting 41 Motion for Judgment on the Pleadings; granting 69 Motion to Dismiss for Lack of Jurisdiction; granting 112 Motion to Dis miss; granting 113 Motion to Dismiss; granting 114 Motion for Judgment on the Pleadings; granting 140 Motion to Amend/Correct; granting 168 Motion to Dismiss; granting 197 Motion to Dismiss; granting 198 Motion to Dismiss, as more fully set out. Signed by Honorable David L. Russell on 61/16. (jw)

IN THE UNITED STATES DISTRICT COURT FOR THE
WESTERN DISTRICT OF OKLAHOMA

JLEE COLEAN, et al.,
Plaintiffs,
vs.
PD-RX PHARMACEUTICALS INC., et al.,
Defendants.

)
)
)
)
)
)
)
)
)
)

Civil Action No. 5:15-cv-00563-R

ORDER
Before the Court is are joint motions to dismiss the claims of all Plaintiffs against
Defendants Eli Lilly and Company, Teva Pharmaceuticals USA, Inc.; Defendant Watson
Pharmaceuticals, Inc. n/k/a Actavis, Inc.; Defendants Neosan Pharmaceuticals, Inc.,
AAIPharma Development Services, Inc., AAIPharama, Inc., and AAIPharma, LLC;
Defendants Cornerstone Biopharma, Inc., and Cornerstone Biopharma Holdings, LLC
(formerly known as and sued herein as Cornerstone Biopharma Holdings, Inc.);
Defendants Mallinckrodt Inc. and Covidien Inc.; and Defendants Mylan Pharmaceuticals
Inc. and Mylan Inc. Doc. Nos. 197, 198.
Upon due consideration, the Court GRANTS the Motions. Plaintiffs’ claims
against these Defendants are DISMISSED WITH PREJUDICE.

IT IS SO ORDERED, this 1st day of June, 2016.